For further inquiries, please contact email@example.com. For Korean customers, please contact Sartorius (RoosterBio’s partner in Korea): firstname.lastname@example.org. To learn more about hMSCs and scalable manufacturing, visit our blog for highly informative, educational articles.
RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and exosome/extracellular vesicle (EV) product and process development to fuel the rapid commercialization of scalable regenerative cures. Our high-quality hMSCs, bioprocess media, genetic engineering tools, and exosome production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing at reduced cost and increased productivity. With optimized, scalable processes, Type 2 Drug Master Files, and cGMP products, we have enabled therapeutic programs to traverse their path to clinical translation in under 1 year.
RoosterBio is driven by our client’s success and creating a world where safe and effective regenerative medicines are rapidly developed and widely available on a global scale.